SCHEMBL3514942

SCHEMBL3514942

COc1[c]nccc1C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
NNMT P40261 4/20 0.41
SIRT3 Q9NTG7 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
PARP1 P09874 3/20 0.36
PARP10 Q53GL7 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
PARP4 Q9UKK3 1/20 0.36
IKBKB O14920 1/20 0.35
ALDH1A1 P00352 2/20 0.34
GLA P06280 2/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 1/20 0.34
CDC7 O00311 2/20 0.34
CASP1 P29466 1/20 0.34
CCNE1 P24864 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067793 0.84 LMNA (0.41) KDM4ETDP1CA1CA2ALDH1A1
SCHEMBL2066800 0.79 PLK1 (0.41) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL4275479 0.76 SIRT3 (0.48) KDM4ENNMTSIRT3TDP1MKNK1
SCHEMBL15414819 0.72 SIRT3 (0.36) KDM4ESIRT3TDP1MKNK1MKNK2
SCHEMBL2068085 0.71 IKBKB (0.40) KDM4ENNMTTDP1MKNK1MKNK2
SCHEMBL3430889 0.71
SCHEMBL2066424 0.71
SCHEMBL22396517 0.70 KDM4E (0.43) KDM4EMKNK1MKNK2ALDH1A1GLA
SCHEMBL3929070 0.69 PARP1 (0.41) KDM4ENNMTPARP1PARP10CA1
SCHEMBL2067156 0.69 ALDH1A1 (0.41) KDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2014-01-02 US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 US disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 KDM4E 1280/4885NNMT 1608/4885SIRT3 876/4885
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 KDM4E 1280/4885NNMT 1608/4885SIRT3 876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.